Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Shock. 2014 Sep;42(3):256–263. doi: 10.1097/SHK.0000000000000213

Figure 6. Protection of liver and kidney against caspase-3 activation in liver (A) and kidney (B).

Figure 6

Caspase-3 activity was measured in liver and kidney homogenates at 6 h after HS/R. *p <0.05 vs vehicle, n=6 per group. Dox, doxycycline; Min, minocycline; Post, post-treatment; Pre, pre-treatment; Tet, tetracycline.